Consequently, using collected patient questionnaire data from the database of the Department of Pathology, Cancer Hospital, along with the corresponding KRAS and BRAF mutational status, we evaluated the associations between tumor molecular and epidemiological features. This evidence concerns the gene KRAS and cancer.